Both MDC1A and partial merosin deficiency, as well as other rare clinical phenotypes associated with LAMA2 mutations, are all classified as LAMA2-MD (Oliveira et al., 2018; Verma et al., 2018; Amin et al., 2019). Here, LAMA2 is linked to hyperinsulinemic hypoglycemia, familial, 4.